(Q37319114)

19 August 2017

1 reference

title

Polymeric micellar delivery systems in oncology (English)

1 reference

19 August 2017

Yasuhiro Matsumura

1

1 reference

19 August 2017

publication date

6 November 2008

1 reference

Japanese Journal of Clinical Oncology

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

12

1 reference

19 August 2017

page(s)

793-802

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

19 August 2017

1 reference

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYN116

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYN116

1 reference

19 August 2017

1 reference